chemoimmunotherapy in tnbc: the impassion130 trial
Published 5 years ago • 514 plays • Length 8:42Download video MP4
Download video MP3
Similar videos
-
4:53
chemoimmunotherapy in tnbc: the keynote-355 trial
-
6:56
impassion130 trial data on pd-l1 tumors in tnbc
-
4:33
i-o in tnbc: impassion130 trial design and results
-
2:51
impassion130: design and preliminary efficacy
-
7:19
impassion130 trial: os updates in metastatic tnbc
-
2:07
tnbc: using checkpoint inhibitors alone or with chemotherapy
-
4:47
tnbc: updated efficacy results from impassion130
-
2:33
applying impassion130 data to tnbc management
-
1:39
dr. rugo on takeaways from the impassion130 trial in tnbc
-
1:16
the impassion130 trial in metastatic triple-negative breast cancer
-
6:54
impassion130 trial data on pd-l1 tumors in tnbc
-
0:52
dr. burris on predictive biomarkers for chemoimmunotherapy in tnbc
-
6:01
immunotherapy for triple-negative breast cancer
-
1:46
dr. schmid discusses the findings of impassion130 in tnbc
-
1:43
dr. rugo on the results of the keynote-522 trial in tnbc
-
4:27
analysis of impassion130: pd-l1 testing in advanced tnbc
-
2:44
impassion130: addressing immune-related aes in tnbc management
-
0:59
impassion130 data demonstrate clinical benefit for immunotherapy in metastatic tnbc
-
4:11
immunotherapy for tnbc: impassion130 & keynote-355